EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 9.29

Change

-0.50 (-5.11)%

Market Cap

N/A

Volume

2.09M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

+0.63 (+1.20%)

USD 10.98B
WEAV Weave Communications Inc

+0.24 (+2.55%)

USD 0.71B
AMWL American Well Corp

-0.07 (-0.97%)

USD 0.12B
CTEV Claritev Corporation

+0.79 (+3.81%)

N/A
PHR Phreesia Inc

+0.14 (+0.59%)

N/A
TDOC Teladoc Inc

-0.10 (-1.38%)

N/A
VEEV Veeva Systems Inc Class A

-0.94 (-0.42%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

-0.12 (-0.41%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.42% 50% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.42% 50% F 17% F
Trailing 12 Months  
Capital Gain -69.20% 13% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -69.20% 13% F 2% F
Trailing 5 Years  
Capital Gain 55.35% 100% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.35% 100% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 25.05% 90% A- 87% B+
Dividend Return 25.05% 90% A- 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 66.03% 30% F 12% F
Risk Adjusted Return 37.93% 80% B- 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.